Heights Capital cuts Faron Pharmaceuticals voting rights to 20.52%

• Heights Capital Management cut its total voting rights stake to 20.52% from 21.41% on July 22, 2026.
• Direct shareholding fell to 7.99% from 8.88%, equal to 18,214,836 voting rights.
• Voting rights via Convertible Bond instruments stayed at 12.53%, equal to 28,560,000 voting rights.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Faron Pharmaceuticals Oyj published the original content used to generate this news brief on July 24, 2026, and is solely responsible for the information contained therein.